Clinical Trials on Patient Refusal of Treatment in Argentina

Total 3 results

Hospital Nacional Profesor Alejandro Posadas
Instituto Ecuatoriano de Enfermedades Digestivas; Hospital Nacional Cayetano...

Recruiting

Role of Information and Communication Technologies for Health Support in Inflammatory Bowel Diseases: The DAMASCO Trial (DAMASCO)

Quality of Life | Inflammatory Bowel Diseases | Knowledge, Attitudes, Practice | Treatment Adherence and Compliance

Argentina
Latin American Cooperative Oncology Group
GlaxoSmithKline

Completed

Safety Study in Subjects With Metastatic Breast Cancer Who Progressed After Taxanes Treatment. (GLICO-0801)

BRMS1 | Performance Status Zero to Two for Beginning the Study | Patient With a Maximum of One Chemotherapy | Patient With Progression After Taxanes

Argentina, Brazil, Peru
Bayer

Active, not recruiting

A Study to Learn How Safe the Study Treatment BAY94-9027 is and How it Affects the Body in Previously Treated Children Aged 7 to Less Than 12 Years With Severe Hemophilia A, a Genetic Bleeding Disorder That is Caused by the Lack of a Protein Called Clotting Factor 8 (FVIII) in the Blood (Alfa-PROTECT)

Hemophilia A | Children | Prophylaxis of Bleeding | Treatment of Bleeding

Canada, United States, Brazil, Italy, Turkey, Argentina, Norway

3

Subscribe